Response to dacomitinib in advanced non-small-cell lung cancer harboring the rare delE709_T710insD mutation: A case report

Figure 1 Positron emission tomography scans at presentation.

Figure 2 Chest computed tomography scans. A: Chest computed tomography scans before (A) and after dacomitinib therapy; B and C: The patient achieved partial response 2 mo after the initiation of dacomitinib therapy and progressed at 7 mo later.